What is the global uveitis treatment market in 2026?

The global uveitis treatment market is projected to be valued at US$ 905.8 million in 2026.

What drives the global uveitis treatment market?

Rising uveitis prevalence, growing autoimmune disease burden, and increasing adoption of advanced corticosteroid and biologic therapies drive market growth.

What is the growth rate for the global uveitis treatment market?

The global market is poised to witness a CAGR of 7.3% between 2026 and 2033.

What are the key uveitis treatment market opportunities?

Expanding clinical pipeline with novel TYK2/JAK1 modulators, IL-6 inhibitors, and sustained-release ocular implants creates strong future market opportunities.

Who are the key players in the global uveitis treatment market?

Major players in the global are Novartis AG, Bausch & Lomb Incorporated, AbbVie Inc., Fresenius Kabi AG, Santen Pharmaceutical Co., Ltd., Genentech, Inc., and others.

Table of Content - Uveitis Treatment Market Size, Trends, Share, Growth, and Regional Forecast, 2026

Executive Summary
1. Global Uveitis Treatment Market Snapshot, 2026 and 2033
2. Market Opportunity Assessment, 2026 - 2033, US$ Mn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Key Trends
3. Macro-Economic Factors
  1. Global Sectorial Outlook
  2. Global GDP Growth Outlook
4. COVID-19 Impact Analysis
5. Forecast Factors - Relevance and Impact
Value Added Insights
1. Product Adoption Analysis
2. Regulatory Landscape
3. Value Chain Analysis
4. Key Deals and Mergers
5. PESTLE Analysis
6. Porter’s Five Force Analysis
Global Uveitis Treatment Market Outlook:
1. Key Highlights
  1. Market Volume (Units) Projections
  2. Market Size (US$ Mn) and Y-o-Y Growth
  3. Absolute $ Opportunity
2. Market Size (US$ Mn) Analysis and Forecast
  1. Historical Market Size (US$ Mn) Analysis, 2020-2025
  2. Market Size (US$ Mn) Analysis and Forecast, 2026-2033
3. Global Uveitis Treatment Market Outlook: Drug Class
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Drug Class, 2020-2025
  3. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2026-2033
    1. Corticosteroids
    2. Immunosuppressant
    3. Monoclonal Antibodies
    4. Cycloplegic Agents
    5. Antibiotics
    6. Antivirals
    7. Antifungal
    8. Analgesics
  4. Market Attractiveness Analysis: Drug Class
4. Global Uveitis Treatment Market Outlook: Indication
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Indication, 2020-2025
  3. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
    1. Anterior Uveitis
    2. Posterior Uveitis
    3. Intermediate Uveitis
    4. Panuveitis
  4. Market Attractiveness Analysis: Indication
5. Global Uveitis Treatment Market Outlook: Disease Etiology
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Disease Etiology, 2020-2025
  3. Market Size (US$ Mn) Analysis and Forecast, By Disease Etiology, 2026-2033
    1. Infectious Uveitis
    2. Non-infectious Uveitis
  4. Market Attractiveness Analysis: Disease Etiology
6. Global Uveitis Treatment Market Outlook: Distribution Channel
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2020-2025
  3. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026-2033
    1. Hospital Pharmacies
    2. Retail Pharmacies
    3. Online Pharmacies
  4. Market Attractiveness Analysis: Distribution Channel
Global Uveitis Treatment Market Outlook: Region
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Region, 2020-2025
3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2026-2033
  1. North America
  2. Europe
  3. East Asia
  4. South Asia and Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Uveitis Treatment Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
  1. By Country
  2. By Drug Class
  3. By Indication
  4. By Disease Etiology
  5. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
  1. U.S.
  2. Canada
4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2026-2033
  1. Corticosteroids
  2. Immunosuppressant
  3. Monoclonal Antibodies
  4. Cycloplegic Agents
  5. Antibiotics
  6. Antivirals
  7. Antifungal
  8. Analgesics
5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
  1. Anterior Uveitis
  2. Posterior Uveitis
  3. Intermediate Uveitis
  4. Panuveitis
6. Market Size (US$ Mn) Analysis and Forecast, By Disease Etiology, 2026-2033
  1. Infectious Uveitis
  2. Non-infectious Uveitis
7. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026-2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
8. Market Attractiveness Analysis
Europe Uveitis Treatment Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
  1. By Country
  2. By Drug Class
  3. By Indication
  4. By Disease Etiology
  5. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Türkiye
  8. Rest of Europe
4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2026-2033
  1. Corticosteroids
  2. Immunosuppressant
  3. Monoclonal Antibodies
  4. Cycloplegic Agents
  5. Antibiotics
  6. Antivirals
  7. Antifungal
  8. Analgesics
5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
  1. Anterior Uveitis
  2. Posterior Uveitis
  3. Intermediate Uveitis
  4. Panuveitis
6. Market Size (US$ Mn) Analysis and Forecast, By Disease Etiology, 2026-2033
  1. Infectious Uveitis
  2. Non-infectious Uveitis
7. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026-2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
8. Market Attractiveness Analysis
East Asia Uveitis Treatment Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
  1. By Country
  2. By Drug Class
  3. By Indication
  4. By Disease Etiology
  5. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
  1. China
  2. Japan
  3. South Korea
4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2026-2033
  1. Corticosteroids
  2. Immunosuppressant
  3. Monoclonal Antibodies
  4. Cycloplegic Agents
  5. Antibiotics
  6. Antivirals
  7. Antifungal
  8. Analgesics
5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
  1. Anterior Uveitis
  2. Posterior Uveitis
  3. Intermediate Uveitis
  4. Panuveitis
6. Market Size (US$ Mn) Analysis and Forecast, By Disease Etiology, 2026-2033
  1. Infectious Uveitis
  2. Non-infectious Uveitis
7. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026-2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
8. Market Attractiveness Analysis
South Asia & Oceania Uveitis Treatment Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
  1. By Country
  2. By Drug Class
  3. By Indication
  4. By Disease Etiology
  5. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of South Asia & Oceania
4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2026-2033
  1. Corticosteroids
  2. Immunosuppressant
  3. Monoclonal Antibodies
  4. Cycloplegic Agents
  5. Antibiotics
  6. Antivirals
  7. Antifungal
  8. Analgesics
5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
  1. Anterior Uveitis
  2. Posterior Uveitis
  3. Intermediate Uveitis
  4. Panuveitis
6. Market Size (US$ Mn) Analysis and Forecast, By Disease Etiology, 2026-2033
  1. Infectious Uveitis
  2. Non-infectious Uveitis
7. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026-2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
8. Market Attractiveness Analysis
Latin America Uveitis Treatment Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
  1. By Country
  2. By Drug Class
  3. By Indication
  4. By Disease Etiology
  5. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
  1. Brazil
  2. Mexico
  3. Rest of Latin America
4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2026-2033
  1. Corticosteroids
  2. Immunosuppressant
  3. Monoclonal Antibodies
  4. Cycloplegic Agents
  5. Antibiotics
  6. Antivirals
  7. Antifungal
  8. Analgesics
5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
  1. Anterior Uveitis
  2. Posterior Uveitis
  3. Intermediate Uveitis
  4. Panuveitis
6. Market Size (US$ Mn) Analysis and Forecast, By Disease Etiology, 2026-2033
  1. Infectious Uveitis
  2. Non-infectious Uveitis
7. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026-2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
8. Market Attractiveness Analysis
Middle East & Africa Uveitis Treatment Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
  1. By Country
  2. By Drug Class
  3. By Indication
  4. By Disease Etiology
  5. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2026-2033
  1. Corticosteroids
  2. Immunosuppressant
  3. Monoclonal Antibodies
  4. Cycloplegic Agents
  5. Antibiotics
  6. Antivirals
  7. Antifungal
  8. Analgesics
5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
  1. Anterior Uveitis
  2. Posterior Uveitis
  3. Intermediate Uveitis
  4. Panuveitis
6. Market Size (US$ Mn) Analysis and Forecast, By Disease Etiology, 2026-2033
  1. Infectious Uveitis
  2. Non-infectious Uveitis
7. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026-2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
8. Market Attractiveness Analysis
Competition Landscape
1. Market Share Analysis, 2025
2. Market Structure
  1. Competition Intensity Mapping By Market
  2. Competition Dashboard
3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  1. Novartis AG
    1. Overview
    2. Segments and Products
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. Bausch & Lomb Incorporated
  3. AbbVie Inc.
  4. Fresenius Kabi
  5. Santen Pharmaceutical Co., Ltd.
  6. Genentech, Inc.
  7. KODIAK SCIENCES INC.
  8. ARCTIC VISION HONG KONG BIOTECH LIMITED
  9. Surrozen
  10. Tarsier® Pharma
  11. EyePoint Pharmaceuticals
  12. ANI Pharmaceuticals, Inc.
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Uveitis Treatment Market Size, Trends, Share, Growth, and Regional Forecast, 2026 - 2033

Uveitis Treatment Market by Drug Class (Corticosteroids, Immunosuppressants, Monoclonal Antibodies, Cycloplegic Agents, Antibiotics, Antivirals, Antifungal, Analgesics), Indication, Disease Etiology, Distribution Channel, and Regional Analysis from 2026 - 2033

Quick Links

Our Partners

Secure Payments Through